首页> 外文期刊>Chimia >Pharmacophore-Based Screening for the Successful Identification of Bio-Active Natural Products
【24h】

Pharmacophore-Based Screening for the Successful Identification of Bio-Active Natural Products

机译:基于药理学的筛选方法可成功鉴定生物活性天然产物

获取原文
获取原文并翻译 | 示例
       

摘要

We report on the impact of pharmacophore-based virtual screening in the field of drug discovery from natural products. Confronted by an increasing number of secondary metabolites and an increasing number of bio-molecular targets relevant in the therapy of human disorders, there is clearly the need for efficient data management. Filtering of compounds by virtual screening experiments already showed great effect when dealing with large libraries of potential bioactive molecules. Feature-based 3D pharmacophores have been successfully utilized for database mining in order to retrieve potentially bio-active molecules. However, for the discovery of natural lead candidates, the application of such in silico tools has been so far almost neglected. There seems to be several reasons for this. One concerns the scarce availability of natural product (NP) 3D databases in contrast to synthetic/combinatorial compound libraries; another reason might be the problematic compatibility of NPs with modern robotized high-throughput-screening (HTS) technologies. Additionally, the incalculable availability of pure natural compounds and their often too complex chemistry is claimed to hamper such an approach. Thus, research in this field appears time-consuming, highly complex, expensive, and ineffective. Nevertheless, naturally derived compounds are still among the most favorable sources of new drug candidates. A more rational and economic search for new lead structures originating from nature must therefore be a priority in order to overcome these problems.
机译:我们报告了基于药效团的虚拟筛选在天然药物发现领域中的影响。面对越来越多的与人类疾病治疗相关的次级代谢产物和越来越多的生物分子靶标,显然需要有效的数据管理。通过虚拟筛选实验过滤化合物已显示出在处理大型潜在生物活性分子文库时的巨大效果。基于特征的3D药效团已成功用于数据库挖掘,以检索潜在的生物活性分子。然而,对于发现天然铅候选物而言,迄今为止几乎忽略了这种计算机软件工具的应用。似乎有几个原因。一个问题是与合成/组合化合物库相比,天然产物(NP)3D数据库的稀缺性;另一个原因可能是NP与现代机器人化的高通量筛选(HTS)技术之间的兼容性问题。另外,据称纯天然化合物的不可估量的可用性及其通常过于复杂的化学性质阻碍了这种方法。因此,该领域的研究显得费时,高度复杂,昂贵且无效。然而,天然来源的化合物仍是新药候选者的最有利来源。因此,为了克服这些问题,必须优先考虑对自然界产生的新的铅结构进行更合理和经济的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号